Maciej Garbowski

University College Hospital — United Kingdom

Medicine · Health Sciences

17h-index1.5kcitations47works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(32), Iron Metabolism and Disorders(31), Erythropoietin and Anemia Treatment(10), Erythrocyte Function and Pathophysiology(8), Blood groups and transfusion(5)

Publications47 total

Iron Chelation Efficiency in Human Hepatocytes Is Enhanced By Exogenous Hepcidin
Blood·2023· 1 cited
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia
American Journal of Hematology·2023· 27 citedOpen Access
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration
American Journal of Hematology·2022· 11 citedOpen Access
Outcome predictors for maternal red blood cell alloimmunisation with anti‐K and anti‐D managed with intrauterine blood transfusion
British Journal of Haematology·2021· 12 citedOpen Access
Response to Cabantchik and Hershko commentary “Plasma nontransferrin bound iron–nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation”
American Journal of Hematology·2021Open Access
Luspatercept Redistributes Body Iron to the Liver in Transfusion-Dependent-Thalassemia (TDT) during Erythropoietic Response
Blood·2021· 2 cited
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development
Expert Review of Hematology·2021· 23 citedOpen Access
New insights into the molecular mechanisms underlying the pro-atherosclerotic and vasculo-toxic effect of iron
Atherosclerosis·2020
Maternal Red Blood Cell Alloimmunization Managed with Intrauterine Blood Transfusion: Predictors of Poor Outcome
Blood·2020
Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial
Blood·2020· 2 cited
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways
Haematologica·2020· 40 citedOpen Access
Extracts of Thai<i>Perilla frutescens</i>nutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells
Bioscience Reports·2020· 12 citedOpen Access
Is There a Role for Titre Monitoring in Kell Alloimmunized Pregnancies?
Blood·2019· 5 cited
Evaluating the Volumetric Liver Fat Fraction in Patients Referred for Investigation of Hyperferritinemia
Blood·2019
NTBI Is Transiently Generated from Two Compartments during a Single Dose of Intravenous Iron - a Randomized Controlled Clinical Study
Blood·2019· 4 cited
Practical guide to quantification of hepatic iron with MRI
European Radiology·2019· 126 citedOpen Access
S1631 UNEXPECTED DIFFERENCES IN CARDIAC IRON METABOLISM AND SURVIVAL IN HAMP‐KO AND FPN(C326S) MICE
HemaSphere·2019Open Access
Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction
European Heart Journal·2019· 295 cited
Real-World Experience of Switching from Deferasirox Dispersible to Film-Coated Tablets: Impact on Adherence to Chelation Therapy, Iron Overload and Renal Function
Blood·2018· 4 cited
GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia
Blood·2018
page 1 of 3Next →

Frequent Co-authors

John B. Porter(36), Robert C. Hider(8), Patricia Evans(7), Dudley J. Pennell(6), Olivier Hermine(6), Maria Domenica Cappellini(5), Raffaella Origa(5), Jean‐Antoine Ribeil(5), Dimana Miteva(5), John‐Paul Carpenter(4), Ersi Voskaridou(4), Alì Taher(4), Giovanna Graziadei(4), Martin Schwickart(4), Sandro Altamura(3), Martina U. Muckenthaler(3), Gillian Smith(3), Taigang He(3), Evangelia Vlachodimitropoulou(3), Gian Luca Forni(3)